Migdal Insurance & Financial Holdings’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,276
Closed -$434K 833
2018
Q3
$434K Buy
2,276
+1,288
+130% +$237K 0.01% 402
2018
Q2
$165K Buy
988
+958
+3,193% +$154K ﹤0.01% 456
2018
Q1
$5K Sell
30
-220
-88% -$36.9K ﹤0.01% 573
2017
Q4
$41K Buy
+250
New +$44.9K ﹤0.01% 427
2017
Q3
Sell
-1,170
Closed -$286K 594
2017
Q2
$286K Sell
1,170
-2,603
-69% -$612K 0.01% 257
2017
Q1
$906K Buy
+3,773
New +$879K 0.02% 167

Other funds holding AGN

Migdal Insurance & Financial Holdings's AGN Position: Q4 2018 in Review

Migdal Insurance & Financial Holdings sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 2,276 shares — an estimated $434K sold.

Migdal Insurance & Financial Holdings first reported a position in AGN in Q1 2017 and held it in 6 quarters. The position peaked at $906K in Q1 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Migdal Insurance & Financial Holdings reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 2,276 Allergan plc shares in Q4 2018, an estimated $434K.
  • Migdal Insurance & Financial Holdings first reported a position in Allergan plc in Q1 2017 and held it in 6 quarters.
  • Migdal Insurance & Financial Holdings's Allergan plc position peaked at $906K in Q1 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2018, filed 13 Feb 2019.